Episurf Medical Past Earnings Performance

Past criteria checks 0/6

Episurf Medical's earnings have been declining at an average annual rate of -8.5%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 18.9% per year.

Key information

-8.5%

Earnings growth rate

38.8%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate18.9%
Return on equity-143.0%
Net Margin-845.0%
Next Earnings Update12 Jul 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Episurf Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:16E Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2411-92430
31 Dec 2310-95470
30 Sep 239-97490
30 Jun 237-94480
31 Mar 237-84430
31 Dec 227-77400
30 Sep 2214-72390
30 Jun 2212-71380
31 Mar 229-69350
31 Dec 217-69340
30 Sep 217-67320
30 Jun 217-66320
31 Mar 215-63290
31 Dec 205-64290
30 Sep 205-66280
30 Jun 205-69270
31 Mar 205-73290
31 Dec 195-70280
30 Sep 195-66280
30 Jun 195-62260
31 Mar 194-59260
31 Dec 184-58270
30 Sep 184-58290
30 Jun 183-59310
31 Mar 183-55310
31 Dec 173-61330
30 Sep 173-64340
30 Jun 172-65330
31 Mar 172-69320
31 Dec 162-62280
30 Sep 167-57300
30 Jun 168-53310
31 Mar 167-48300
31 Dec 157-44270
30 Sep 152-38210
30 Jun 152-34180
31 Mar 152-32140
31 Dec 142-33130
30 Sep 143-31110
30 Jun 142-2880
31 Mar 142-2670
31 Dec 132-2370
30 Sep 130-23-10

Quality Earnings: 16E is currently unprofitable.

Growing Profit Margin: 16E is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 16E is unprofitable, and losses have increased over the past 5 years at a rate of 8.5% per year.

Accelerating Growth: Unable to compare 16E's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 16E is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: 16E has a negative Return on Equity (-143.01%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.